Spanish hospitals owe drugmakers $7.5B; FDA postpones Copaxone decision;

@FiercePharma: Oncologists lament growing drug shortages. Report | Follow @FiercePharma

> The amount Spain's public hospitals owe drug companies rose 11 percent to €5.12 billion ($7.5 billion) in the first quarter of 2011, industry association Farmaindustria said. Story

> FDA has postponed a ruling on a citizens petition from Teva Pharmaceutical Industries seeking to prevent the launch of generic versions of its multiple sclerosis drug Copaxone. Article

> Abbott Laboratories hopes a recent leadership change atop its nutrition business will spur improved profitability, which has lagged that of rival Mead Johnson Nutrition. Report

> Somaxon Pharmaceuticals has tapped Paladin Labs to market the sleep treatment Silenor in Canada, South America and Africa. Release

> Impax Laboratories shares dropped 11 percent in early trading Wednesday after analysts at J.P. Morgan cut their rating of the stock to neutral from overweight. Article

> Europe's pharmaceutical industry has warned that a review of E.U. law could undermine the pricing and reimbursement of medicines. Item

Biotech News

@FierceBiotech: What's in a (drug) name? Article | Follow @FierceBiotech

@JohnCFierce: Still early days on the Ph2 Vertex program. CFF CEO talks about "important new information about the potential to address the basic defect." | Follow @JohnCFierce

> Polaris chief balances woes with pros of biotech investing. Report

> Selecta teams with diabetes foundation on Type 1 vaccine. Article

> Vertex shares slide as CF drug combo raises questions in Ph2. Story

> Pfizer unveils $100M Boston effort to spark R&D innovation. Report

Pharma Manufacturing News

> Novartis leans on CMOs for ops gains. Article

> HP primed for large-scale track/trace. Report

> Disposables maker goes solar, targeting energy costs. Story

> Glass chips prompt another American Regent recall. Item

> India yanks license of uncooperative Chinese supplier. News

> Sun, Max RFID pilot advances. Report

Vaccine News

> Adult vaccines cut down on healthcare costs. Article

> UCFS researchers unveil promising glioblastoma vaccine data. Report

> Vaccine makers cut prices for developing countries. Story

> J&J, GSK team on malaria vaccine. Article

> Vaxart starts Ph1 oral vax trial. Item

And Finally... Lower cholesterol and blood pressure levels helped cut the risk of having a heart attack in the U.K. by 74 percent over two decades, though rising obesity rates may undermine that progress, researchers said. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.